Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-04-02
1999-01-26
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514438, 514532, 514559, 514617, 514622, 514725, A61K 3120
Patent
active
RE0360686
ABSTRACT:
Various effects of photoaging or sundamage of skin including impairment of differentiation of epidermal epithelial cells and loss of collagen fibers, abnormal changes in elastic fibers and deterioration of small blood vessels in the dermis of the skin are retarded by applying topically to the epidermis in a maintenance therapy program effective amounts of retinoids including retinoid derivatives and stereoisomers thereof such that epithelial growths are substantially reduced and prevented and the skin substantially regains and maintains its firmness, turgor and elasticity. Moreover, with persistent treatment dermal blood cells and vessels increase and the epidermis and dermis thicken, resulting in improved ability of the skin to sense, resist and recover from irritation or injury. Further, hyperpigmentation, lines and wrinkles due to aging are reduced and prevented. The treatment is particularly useful for human facial skin and preferably applied in amounts insufficient to cause excessive irritation.
REFERENCES:
patent: 3729568 (1973-04-01), Marks
patent: 3856934 (1974-12-01), Felty
patent: 3906108 (1975-09-01), Felty
patent: 4247547 (1981-01-01), Marks
patent: 4396553 (1983-08-01), Klaus
patent: 4603146 (1986-07-01), Kligman
patent: 4877805 (1989-10-01), Kligman
patent: 4888342 (1989-12-01), Kligman
See Attachment--Part I, Listing of Infomration from Kligman and Bryce File Histories (3 pages).
See Attachment--Part II, Record of Interference No. 102,638 (22 pages).
U.S. Ser. No. 297,388 (Abandoned).
Thomas et al., Journal of American Academy of Dermatology (May 1981), vol. 4, No. 5, pp. 505-513.
U.K. 906,000, Sep. 1962.
U.S. Serial No. 610,711 (Abandoned).
Kligman et al., Archives of Dermatology (Oct., 1971), vol. 104, pp. 420 and 421.
Kligman et al., Archives of Dermatology (Jan., 1975), vol. 111, pp. 40-48.
Robinson et al., British Journal of Dermatology (1975), vol. 92, pp. 703-706.
Kligman et al., Journal of Investigative Dermatology (1979), vol. 73, pp. 354-358.
U.S. Ser. No. 759,505 (Issued as the '146 Patent).
U.S. 4,603,146, Jul. 1986, 514/559.
U.S. Ser. No. 886,595 (Abandoned).
U.K. 1,466,062, Mar. 1977.
FR 1,297,730 May, 1972.
Pawson et al., Journal of Medicinal Chemistry (1982), vol. 25, pp. 1269-1277.
Saurat (editor), Symposium Publication--Karger Publishing Company (1985) ("Retinoids: New Trends in Research and Therapy").
Pawson (Deluca et al. editors), Annals of the New York Academy of Sciences (1981), vol. 359, pp. 1-13.
UK 1,335,867, Oct. 1973.
Sporn et al., 1985 Retinoids, Differentiation and Disease, vol. 113, pp. 1-5.
Elias et al. (editors), Topical Retinoids: An Update--Proceedings of a Symposium held Apr. 19-20, 1986, pp. 748-156.
Bollag (Saurat editor), Retinoids: New Trends in Research and Therapy (1985), pp. 274-288.
Sporn et al. (editors), The Retinoids (1984), vol. 1, pp. 393-413; Newton et al., Cancer Research (1980), vol. 40, pp. 3413-3425.
Loeliger et al., European Journal of Medicinal Chemistry--Chimica Therapeutica (Jan.-Feb. 1980), vol. 15, No. 1, pp. 9-15. cited!.
U.S. Ser. No. 205,057 (issued as the '805 Patent).
Saline, Philadelphia Magazine (1980), pp. 102-133.
Industry Happenings, Drug & Cosmetic, Industries (1985), p. 86.
UK 1,239,965, Jul. 1981.
FR 2,405,068 Oct. 1977.
German 2,240,187 Feb. 1974.
BE 877,713 Nov. 1979.
Mayer et al., Experientia (1978), vol. 34.
Trown, Cancer Research (1980), vol. 40, p. 212.
U.S. Ser. No. 86,992 (Abandoned).
U.S. Ser. No. 219,616 (Abandoned).
EPA 253,393, Jan. 1988.
UK Application 906,000, Sep. 1962.
U.S. Ser. No. 520,166 (Pending) 1995.
Declaration of Dr. Graeme Bryce.
Declaration of Dr. Stanley Shapiro, 1996.
Declaration of Nancy Bogdan, 1996.
Declaration of Corine Brown, 1996.
Order to Show Cause, PTO, Dec. 31, 1991.
Notice--Case Has Been Forwarded to the Board of Patent Appeals and Ints, PTO, Dec. 31, 1991.
Notice: Interference Assigned to EIC Downey, PTO, Dec. 31, 1991.
Identification of Lead Attorney, Bryce, Jan. 14, 1992.
Change of Lead Attorney and Associate Power of Attorney, Kligman, Jan. 24, 1992.
Associate Power of Attorney, Bryce, Jan. 27, 1992.
Unopposed Request for Extension of Time (Approved Jan. 29, 1992, Mailed Jan. 30, 1992), Bryce, Jan. 29, 1992.
Order: Party Bryce' Request for Permission to Obtain Subpoena to Take Testimony of a Witness Concerning Public Use Denied, PTO, Feb. 6, 1992.
Notice of Party-In-Interest Under 37 C.F.R. Section 1.602, Kligman, Feb. 7, 1992.
Request for One Day Extension of Time, Bryce, Mar. 2, 1992.
Bryce, et al. Response to Order to Show Cause and Request for Final Hearing, Bryce, Mar. 3, 1992.
Bryce, et al. Motion to Redefine the Interfering Subject Matter, Bryce, Mar. 3, 1992.
Communication from the Examiner-In Chief, Declaring the Captioned Interference, Dec. 31, 1991.
The Order to Show Cause, Dec. 31, 1997.
U.S.P. 4,877,805.
U.S.P. 4,603,146.
Office Action from the File History of U.S.P. 4,603,146.
Declaration of James A. Mezick, PH.D. Under 37 C.F.R. 1.132, Taken from the File History of Kligman, U.S.P. 4,877,805, Nov. 30, 1987.
U.S.P. 4,487,782.
Declaration of Albert M. Kligman, from File History of Mezick U.S.P. 4,487,782, Jul. 19, 1986.
Notice of Allowability Taken Form the File History of Kligman, U.S.P. 4,877,805.
The Declaration of Nicholas J. Lowe, from the File History of Mezick, U.S.P. 4,487,782, Jan. 1987.
Declaration of Peter M. Elias, Taken from the File history of Mezick, U.S.P. 4,487,782, Jan. 20, 1987.
Sherman, et al., "Effects of Arotinoids upon Murine Embryonal Carcinoma Cells," Cancer Research, vol. 43, pp. 4283-4290 Sep. 1983.
Klaus, et al., "Sulfur-Containing Arontinoids, a New Class of Retinoids," European Journal of Medicine and Chemistry, vol. 18, No. 5, pp. 425-429 (1983).
W. Bollag, "New Retinoids with Potential Use in Humans," Retinoids: New Trends in Research and Therapy, Saurat (Ed.), Retinoid Symposium, Geneva 1984, pp. 274-288, (Karger, Basel 1985).
Klaus U.S.P. 4,396,553.
Connor, et al. "A Comparative Study of the Induction of Epidermal Hyperplasia by Natural and Synthetic Retinoids," Journal of Pharmacology and Experimental Therapeutic, vol. 237, No. 1, pp. 31-35, 1986.
L. Kligman, "Photoaging Manifestations, Prevention, and Treatment," Dermatologic Clinics, vol. 4, No. 3, pp. 517-528, Jul. 1986.
The Declaration of Dr. Albert M. Kligman, Taken from the File History of Kligman, U.S.P. 4,603,146, Aug. 26, 1982.
Kligman U.S.P. 3,856,934.
Kligman, "Early Destructive Effect of Sunlight on Human Skin," JAMA, vol. 210, No. 13, pp. 2377-2380, Dec. 1969.
Knight Great Britain Patent Specification 1,466,062.
Information Disclosure Statement Taken from File History of Kligman, U.S.P. 4,877,805.
Great Britain Patent Specification 906,000.
Kligman, et al. "Topically Applied Tretinoin for Senile (Solar) Comedones," Arch. Derm., vol. 104, pp. 420-421, Oct. 1971.
Robinson, et al., "Treatment of Solar Keratoses of the Extremities with Retinoic Acid and 5-Flourouracil," British Journal of Dermatology, vol. 92, pp. 703-706.
Saline, "Adventures in the Skin Trade," Philadelphia Magazine, vol. 71, pp. 102-133, Jul., 1980, Saline.
The 1979 Physician's Desk Reference, pp. 927-928.
Kligman, et al., "The Effect on Rhino Mouse Skin of Agents Which Influence Keratinization and Exfoliation," The Journal of Investigative Dermatology, vol. 73, No. 5, Part 1, pp. 354-358, 1979.
Kligman, et al., "Topical Retinoic Acid Enhances the Repair of Ultraviolet Damaged Dermal Connective Tissue," Connective Tissue Research, vol. 12, pp. 139-150, 1984, Kligman.
Kligman, et al., "Enhanced Repair of UV-Induced Dermal Damage by Topical Retinoic Acid", Retinoids: New Trends in Research and Therapy, Saurat (Ed.,) (Karger, Basel 1985).
The Great Britain Patent Specification 1,335,867.
Ashton, et al., "Histologic Changes in the Skin of the Rhino Mouse Induced by Retinoids," Journal of Investigative Dermatology, vol. 82, No. 6, pp. 632-635, 1984.
Copy of Stiefel U.S.P. 4,483,096.
Bryce et al Motion I. for Benefit of Earlier Filing Dates, II. to Deny Kligman Benefit of Earlier Filing Dates, Bryce, Mar. 3, 1992.
Declaration of William H. Epstein, Bryce, Mar. 3, 1992.
Notice of
LandOfFree
Methods for treatment of sundamaged human skin with retinoids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treatment of sundamaged human skin with retinoids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment of sundamaged human skin with retinoids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441814